Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Hangzhou Alltest Biotech Co. Ltd. A
688606Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China. Address: Building 3, 4, 5, Hangzhou, China, 310018
Analytics
Preço Alvo de Wall Street
–Rácio P/E
20.3926Rendimento de dividendos
4.34 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 688606
Análise de Dividendos 688606
Crescimento de dividendos em 5 anos
–Crescimento contínuo
2 anosTaxa de pagamento em média de 5 anos
157 %Histórico de Dividendos 688606
Avaliação de ações 688606
Relatório 688606
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |